Targeted mutations of transforming growth factor-beta genes reveal important roles in mouse development and adult homeostasis.

Transforming growth factors-beta (TGF-beta) are multifunctional molecules with profound biological effects in many developmental processes including regulation of cell proliferation, differentiation, cell adhesion, skeletal development, haematopoiesis, inflammatory responses, and wound healing. To learn about the role of TGF-beta in vivo, phenotypes of targeted mutations of molecules within the TGF-beta signalling pathway, TGF-beta1, -beta2, -beta3, TGF-beta receptor (TbetaR-II) and the signalling molecules SMAD2, SMAD3 and SMAD4, are discussed in this review. The three individual TGF-beta mutants show distinct and only partially overlapping phenotypes. In mice, targeted disruption of the TGF-beta1 gene results in diffuse and lethal inflammation about 3 weeks after birth, suggesting a prominent role of TGF-beta in the regulation of immune cell proliferation and extravasation into tissues. However, just half of the TGF-beta1 (-/-) conceptuses actually reach partuition due to defective haematopoiesis and endothelial differentiation. Targeted disruption of both TGF-beta2 and TGF-beta3 genes results in perinatal lethality. TGF-beta2 null mice exhibit a broad range of developmental defects, including cardiac, lung, craniofacial, limb, eye, ear and urogenital defects, whereas TGF-beta3 gene ablation results exclusively in defective palatogenesis and delayed pulmonary development. The TbetaR-II null phenotype closely resembles that of TGF-beta1 (-/-) conceptuses, which die in utero by E10.5. Loss of SMAD2 or SMAD4 results in related phenotypes: the mutants fail to form an organized egg cylinder, lack mesoderm required for gastrulation and die prior to E8.5. Together, gene ablation within the TGF-beta signalling pathway supports the notion of a prominent role of TGF-beta during development.

[1]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  F. Conlon,et al.  A primary requirement for nodal in the formation and maintenance of the primitive streak in the mouse. , 1994, Development.

[3]  J. Li,et al.  TGF-β3, but Not TGF-β1, Protects Keratinocytes against 12-O-Tetradecanoylphorbol-13-acetate-induced Cell Deathin Vitro and in Vivo * , 1999, The Journal of Biological Chemistry.

[4]  A. Roberts,et al.  Loss of Smad3 modulates wound healing. , 2000, Cytokine & growth factor reviews.

[5]  P. Kondaiah,et al.  Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. , 1991, Development.

[6]  L. Wakefield,et al.  Transforming growth factor-β1 is a new form of tumor suppressor with true haploid insufficiency , 1998, Nature Medicine.

[7]  J. Graff,et al.  Smad3 Mutant Mice Develop Metastatic Colorectal Cancer , 1998, Cell.

[8]  T. Sachs,et al.  Cell polarity and tissue patterning in plants , 1991 .

[9]  Jeffrey L. Wrana,et al.  TGFβ signals through a heteromeric protein kinase receptor complex , 1992, Cell.

[10]  A. Kulkarni,et al.  Targeted deletion of the TGF-beta 1 gene causes rapid progression to squamous cell carcinoma. , 1994, Genes & development.

[11]  K. Unsicker,et al.  Glial Cell Line-Derived Neurotrophic Factor Requires Transforming Growth Factor-β for Exerting Its Full Neurotrophic Potential on Peripheral and CNS Neurons , 1998, The Journal of Neuroscience.

[12]  P. Donahoe,et al.  The type I activin receptor ActRIB is required for egg cylinder organization and gastrulation in the mouse. , 1998, Genes & development.

[13]  A. Geiser,et al.  The Liver in Transforming Growth Factor-Beta-1 (TGF-β1) Null Mutant Mice , 1996 .

[14]  J. Rossant,et al.  The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. , 1998, Genes & development.

[15]  J. Baker,et al.  From receptor to nucleus: the Smad pathway. , 1997, Current opinion in genetics & development.

[16]  A. Geiser,et al.  Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene. , 1998, Bone.

[17]  D. Dickinson,et al.  TGF-beta1 is essential for the homeostasis of the dentin-pulp complex. , 1998, European journal of oral sciences.

[18]  M. Shaw,et al.  Activin receptor-like kinase 2 can mediate atrioventricular cushion transformation. , 2000, Developmental biology.

[19]  M. Ferguson,et al.  Transforming growth factor–β3 is required for secondary palate fusion , 1995, Nature Genetics.

[20]  M. Yin,et al.  Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[21]  K. Flanders,et al.  Expression, localization, and function of transforming growth factor-beta s in embryonic chick spinal cord, hindbrain, and dorsal root ganglia. , 1996, Journal of neurobiology.

[22]  X. F. Wang,et al.  Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor β-Mediated Signal Transduction , 1999, Molecular and Cellular Biology.

[23]  K. Unsicker,et al.  Reduction of endogenous TGF‐β increases proliferation of developing adrenal chromaffin cells in vivo , 2000, Journal of neuroscience research.

[24]  M. Sporn,et al.  The Transforming Growth Factor-βs , 1991 .

[25]  K. Unsicker,et al.  Co-activation of TGF-ss and cytokine signaling pathways are required for neurotrophic functions. , 2000, Cytokine & growth factor reviews.

[26]  P. Hoodless,et al.  Smad2 Signaling in Extraembryonic Tissues Determines Anterior-Posterior Polarity of the Early Mouse Embryo , 1998, Cell.

[27]  M. Sporn,et al.  Role of transforming growth factor-beta in the development of the mouse embryo , 1987, The Journal of cell biology.

[28]  R. Akhurst,et al.  Expression of TGF-beta isoforms during first trimester human embryogenesis. , 1990, Development.

[29]  H. Moses,et al.  Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development , 1991, The Journal of cell biology.

[30]  T. Doetschman,et al.  The TGF-beta2 isoform is both a required and sufficient inducer of murine hair follicle morphogenesis. , 1999, Developmental biology.

[31]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[32]  A. Roberts,et al.  Transforming growth factor‐β1–deficient mice: identification of isoform‐specific activities in vivo , 1996, Journal of leukocyte biology.

[33]  T. Doetschman,et al.  Strain dependency of TGFβ1 function during embryogenesis , 1999 .

[34]  A. Kulkarni,et al.  Immune dysregulation in TGF-beta 1-deficient mice. , 1994, Journal of immunology.

[35]  K. Polyak.  Negative regulation of cell growth by TGFβ , 1996 .

[36]  Scott E. Kern,et al.  Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers , 1996, Nature Genetics.

[37]  A. Kulkarni,et al.  Transforming growth factor-beta 1 null mice. An animal model for inflammatory disorders. , 1995, The American journal of pathology.

[38]  M. Sporn,et al.  Maternal rescue of transforming growth factor-beta 1 null mice. , 1994, Science.

[39]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[40]  K. Flanders,et al.  Effects of TGF-βs and bFGF on Astroglial Cell Growth and Gene Expression in Vitro , 1993, Molecular and Cellular Neuroscience.

[41]  J. Massagué,et al.  The transforming growth factor-beta family. , 1990, Annual review of cell biology.

[42]  M. Yin,et al.  Transforming Growth Factor β1 Enhances Platelet Aggregation through a Non-transcriptional Effect on the Fibrinogen Receptor* , 1999, The Journal of Biological Chemistry.

[43]  Kohei Miyazono,et al.  TGF-β signalling from cell membrane to nucleus through SMAD proteins , 1997, Nature.

[44]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.

[45]  S. Lehnert,et al.  Embryonic expression pattern of TGF beta type-1 RNA suggests both paracrine and autocrine mechanisms of action. , 1988, Development.

[46]  J. Letterio.  Murine models define the role of TGF-beta as a master regulator of immune cell function. , 2000, Cytokine & growth factor reviews.

[47]  G. Dotto,et al.  Control of murine hair follicle regression (catagen) by TGF‐β1 in vivo , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  Irene L Andrulis,et al.  MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.

[49]  M. Sporn,et al.  Expression of transforming growth factor-beta 1 in specific cells and tissues of adult and neonatal mice , 1989, The Journal of cell biology.

[50]  G. Boivin,et al.  Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice. , 1995, The American journal of pathology.

[51]  J. Letterio,et al.  A Role for Endogenous Transforming Growth Factor β1 in Langerhans Cell Biology:  The Skin of   Transforming Growth Factor β1 Null Mice Is Devoid of  Epidermal Langerhans Cells , 1996, The Journal of experimental medicine.

[52]  V. Kaartinen,et al.  Abnormal lung development and cleft palate in mice lacking TGF–β3 indicates defects of epithelial–mesenchymal interaction , 1995, Nature Genetics.

[53]  D. W. Johnson,et al.  Mutations in the activin receptor–like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2 , 1996, Nature Genetics.

[54]  R. Kucherlapati,et al.  Postgastrulation Smad2-deficient embryos show defects in embryo turning and anterior morphogenesis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[55]  P S Gartside,et al.  Transforming growth factor beta1 suppresses nonmetastatic colon cancer at an early stage of tumorigenesis. , 1999, Cancer research.

[56]  K. Kinzler,et al.  Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. , 1995, Science.

[57]  M. Sporn,et al.  Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system , 1991, Neuroscience.

[58]  M. Ferguson,et al.  Pathogenesis of cleft palate in TGF-beta3 knockout mice. , 1999, Development.

[59]  K. Miyazono,et al.  HNPCC associated with germline mutation in the TGF-β type II receptor gene , 1998, Nature Genetics.

[60]  R. Weinberg,et al.  Transforming growth factor beta-induced phosphorylation of Smad3 is required for growth inhibition and transcriptional induction in epithelial cells. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[61]  C. Deng,et al.  Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Massagué,et al.  Transcriptional control by the TGF‐β/Smad signaling system , 2000 .

[63]  M. Ferguson,et al.  Medial edge epithelial cell fate during palatal fusion. , 2000, Developmental biology.

[64]  A. Kulkarni,et al.  Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. , 1995, Development.

[65]  K. Unsicker,et al.  The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions. , 2008, Journal of neurochemistry.

[66]  M. Dickinson,et al.  In situ hybridization analysis of TGF beta 3 RNA expression during mouse development: comparative studies with TGF beta 1 and beta 2. , 1990, Development.

[67]  E. Li,et al.  Smad2 role in mesoderm formation, left–right patterning and craniofacial development , 1998, Nature.

[68]  A. Clarke,et al.  Smad4 (DPC4)--a potent tumour suppressor? , 1998, British Journal of Cancer.

[69]  M. Sporn,et al.  Localization and actions of transforming growth factor-beta s in the embryonic nervous system. , 1991, Development.

[70]  M. Taketo,et al.  TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. , 1996, Developmental biology.

[71]  Fumiko Itoh,et al.  Signaling of transforming growth factor‐β family members through Smad proteins , 2000 .

[72]  T. Musci,et al.  The tumor suppressor Smad4/DPC 4 as a central mediator of Smad function , 1997, Current Biology.

[73]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[74]  P. Schmid,et al.  Differential expression of TGF beta 1, beta 2 and beta 3 genes during mouse embryogenesis. , 1991, Development.